Genus plc risk profile

52 Elevated one input has moved against it

Measured 1 September 2026 from GBE's filed statements. Recomputed nightly.

52 (Elevated), driven by Competitive position at 56, over 3 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation50ElevatedEasingDrawdown from the 52-week high — 22.3%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversion34NormalEasingCapital spending against operating cash — 0.28x
Leverage and coverageReads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company.
Competitive position56ElevatedStableRevenue-growth gap against peers — -24.4 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Genus plc